Latest filing published 30 Jun 2020 for Calliditas Therapeutics AB, €298k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ann-Kristin Lena Myde: trading record in brief
All filings by Ann-Kristin Lena Myde on record concern Calliditas Therapeutics AB. Between 19 December 2018 and 29 June 2020, the trades on record add up to 3 filings.
Purchases make up the whole of the open-market record (1 purchase, €1,145). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 30 June 2020, the filings show a transaction worth €298k in Calliditas Therapeutics AB. The last insider purchase was made public on 20 December 2018, 2,881 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Ann-Kristin Lena Myde
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 73,750 shares@ SEK 42.3699.6% of flowAktieISIN SE0010441584FI:csv-7fafdeaf1f8efe1554aa
- 73,750 shares0TeckningsoptionFI:csv-56f408c90eb28e42d654
- 3,586 shares@ SEK 3.290.4% of flowTeckningsoptionFI:csv-844d33e82bc7a7d64f09Canonical exit: 19 Mar 2019 (T+90)
3 of 3 declarations